Kuros Biosciences announces favorable preliminary results for MagnetOs as standalone alternative to autograft in its first randomized controlled trial.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more